Long-term effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease: a randomised controlled trial
about
Long-acting inhaled therapy (beta-agonists, anticholinergics and steroids) for COPD: a network meta-analysisInhaled steroids and risk of pneumonia for chronic obstructive pulmonary diseaseInhaled corticosteroids for stable chronic obstructive pulmonary diseaseInhaled corticosteroids versus long-acting beta2-agonists for chronic obstructive pulmonary diseaseInhaled corticosteroids versus long-acting beta 2 -agonists for chronic obstructive pulmonary diseaseInhaled corticosteroids versus long acting beta-agonists for chronic obstructive pulmonary diseaseCombined corticosteroid and long-acting beta-agonist in one inhaler versus placebo for chronic obstructive pulmonary diseaseInhaled corticosteroids for stable chronic obstructive pulmonary diseaseOral corticosteroids for stable chronic obstructive pulmonary diseaseEffects of inhaled corticosteroids on sputum cell counts in stable chronic obstructive pulmonary disease: a systematic review and a meta-analysisA re-evaluation of the role of inhaled corticosteroids in the management of patients with chronic obstructive pulmonary diseaseLung cancer chemoprevention: current status and future prospectsEffects of two Chinese herbal formulae for the treatment of moderate to severe stable chronic obstructive pulmonary disease: a multicenter, double-blind, randomized controlled trialMinimal clinically important difference, clinical perspective: an opinion.ICE COLD ERIC--International collaborative effort on chronic obstructive lung disease: exacerbation risk index cohorts--study protocol for an international COPD cohort study.p38 mitogen-activated protein kinase determines the susceptibility to cigarette smoke-induced emphysema in mice.Attenuating immune pathology using a microbial-based intervention in a mouse model of cigarette smoke-induced lung inflammation.Inhaled corticosteroids in chronic obstructive pulmonary disease: a pro-con perspective.Novel therapy for COPD.Treating acute exacerbations of chronic bronchitis.Targeting phosphoinositide-3-kinase-delta with theophylline reverses corticosteroid insensitivity in chronic obstructive pulmonary disease.Evaluation of current pharmacotherapy of chronic obstructive pulmonary disease.Exposing rodents to a combination of tobacco smoke and lipopolysaccharide results in an exaggerated inflammatory response in the lung.Cellular and structural bases of chronic obstructive pulmonary disease.Triamcinolone: new and old indications.Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary.Quantifying the real life risk profile of inhaled corticosteroids in COPD by record linkage analysisPositive benefits of theophylline in a randomized, double-blind, parallel-group, placebo-controlled study of low-dose, slow-release theophylline in the treatment of COPD for 1 year.Inhibition of granulocyte migration by tiotropium bromideEarly detection and management of COPD. What you can do to reduce the impact of this disabling disease.Neutrophil elastase inhibitors as treatment for COPD.Clinical pharmacology = disease progression + drug actionIncident pneumonia and mortality in patients with chronic obstructive pulmonary disease. A double effect of inhaled corticosteroids?Advances in the management of chronic obstructive pulmonary disease.Potential new drugs for therapy of chronic obstructive pulmonary disease.Inhibitory effects of Stemona tuberosa on lung inflammation in a subacute cigarette smoke-induced mouse modelPharmacologic treatment of chronic obstructive pulmonary disease: past, present, and future.Formoterol: a review of its use in chronic obstructive pulmonary disease.Managing the safety of inhaled corticosteroids in COPD and the risk of pneumonia.Mortality and drug therapy in patients with chronic obstructive pulmonary disease: a network meta-analysis.
P2860
Q24197853-E5192D92-FECE-4890-9114-0B6F8967F068Q24197989-6C73328B-DE8E-4AB5-BC8E-C06C3AF1C25BQ24202092-525295A7-997E-483A-B4C7-693A68050BF3Q24234164-960F215D-273B-4040-9710-B96D9D7CE873Q24236037-6834C304-4663-438B-A5FA-D3F22154ABC9Q24243419-04A1D16E-67AE-4D48-B91C-D2C46530D7E1Q24243564-B5F581DF-3F6F-4C28-8608-6BFC48B11D61Q24245481-EBC2FADE-4BA1-4E8F-BCFE-93B0501BA9C3Q24246556-F8638C07-E9E5-48E0-BFC3-3FC6963A6BD3Q24797765-F05B5234-D6B3-4848-AED1-A29B65551F61Q26801661-DC4405AC-F829-4F7B-BE4B-6C0F8B68F0C6Q26995495-AB3E1EB8-B0AF-4D73-969D-3EA6A4A35C54Q28541874-8B70B1EA-E8E0-49F2-BF70-462BE41FF671Q30542113-FD3463E0-C132-4932-B366-35B4035E49D2Q33440006-1175B17B-9DAA-42A9-A804-08608E90505EQ33624820-382C49A7-F89E-4D41-8CA4-7041AC19D5CEQ33692100-BB316C5C-DBBB-4AA8-8A5B-A2AA0C444C13Q34065276-3574D040-828D-4008-87A6-825F8938120FQ34074654-ABE1299F-512B-4849-B1C2-7F1D86CF1DA7Q34099576-ACD3C4A0-AB40-4D38-BE9A-3A6478F7839BQ34103575-D1B362DD-37B5-458D-AC5A-9B24F9BE52D7Q34181964-C44C3E3A-A520-4D3C-B325-095A42C05390Q34219585-BF66B534-2429-41D6-AAC0-1903324B44BAQ34260279-57107B99-98BA-41BE-8F86-FE446C8D00BFQ34388622-E8E09D26-E8E0-4E7A-8E75-8C778CA40231Q34550471-9F5BDBCE-1E82-4933-98D0-71E8727CE8D1Q34551086-3B97EC15-8C8B-48E3-BC7F-274CAF1F3B4FQ34558280-2FF3E118-5F30-4467-9CEF-94D669626B21Q34638204-1E7DC33F-447B-4294-9C05-66A06265DE6FQ34705576-5B496475-702F-4848-9A77-7568E6522DA2Q34706998-0F93C3C0-D10F-43CD-8AE3-AE1D088DE554Q34953659-7B9B5240-23FB-400C-8682-9BF1C336F848Q35140742-A3181783-BEF0-4D4B-986E-03FA8425EA1EQ35164693-DBC2CFAA-37DF-4112-AAB4-A141C10F0A0CQ35164728-B3892574-16BD-4DAF-B2CB-7A0CC089006EQ35191277-3C5ECAAA-03AE-4A4E-9C3F-6791D81D18DEQ35574022-D7DFD616-9130-46B0-964C-CAF6278B14F5Q35627824-329CA2D2-423A-4263-8A93-7B25624E449FQ35675040-189D5EFC-3EC0-47EE-AA9F-62FAA59C0D0EQ35838660-231E1540-0862-444E-961A-594BB8C74A69
P2860
Long-term effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease: a randomised controlled trial
description
article publié dans la revue scientifique The Lancet
@fr
im Mai 1999 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published in The Lancet
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в травні 1999
@uk
ശാസ്ത്രപ്രബന്ധം
@ml
name
Long-term effect of inhaled bu ...... a randomised controlled trial
@en
Long-term effect of inhaled bu ...... a randomised controlled trial
@nl
type
label
Long-term effect of inhaled bu ...... a randomised controlled trial
@en
Long-term effect of inhaled bu ...... a randomised controlled trial
@nl
prefLabel
Long-term effect of inhaled bu ...... a randomised controlled trial
@en
Long-term effect of inhaled bu ...... a randomised controlled trial
@nl
P2093
P1433
P1476
Long-term effect of inhaled bu ...... a randomised controlled trial
@en
P2093
P304
P356
10.1016/S0140-6736(98)10019-3
P407
P577
1999-05-01T00:00:00Z